Evidence map›Paper›PMID 29116753›Full record

ArticleACS nano2017

Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks.

Yue Zhang, Weiwei Gao, Yijie Chen, Tamara Escajadillo, Jessica Ungerleider, Ronnie H Fang, Karen Christman, Victor Nizet, Liangfang Zhang

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Advances in nanomaterial-based targeted drug delivery systems.Frontiers in bioengineering and biotechnology · 2023
    Review
  13. Review
  14. Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Nanoparticle-hydrogel superstructures for biomedical applications.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yue ZhangDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Weiwei GaoDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Yijie ChenDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Tamara EscajadilloDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Jessica UngerleiderDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Ronnie H FangDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Karen ChristmanDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.ORCID 0000-0002-6179-898X
Victor NizetDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.
Liangfang ZhangDepartment of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego , La Jolla, California 92093, United States.ORCID 0000-0003-0637-0654
University of California San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
Safety and Dose Optimization of High-Dose Anakinra in Kawasaki DiseaseU54HD090259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CAPPARELLI, EDMUND VINCENT, NIZET, VICTOR · 2016 to 2018
$2.2M
Safety and Dose Optimization of High-Dose Anakinra in Kawasaki DiseaseP50HD090259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIGAM, SANJAY K · 2019 to 2020
$1.4M
NIAID NIH HHS R01 AI077780NICHD NIH HHS P50 HD090259NICHD NIH HHS U54 HD090259NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Colloidal gels consisting of oppositely charged nanoparticles are increasingly utilized for drug delivery and tissue engineering. Meanwhile, cell membrane-coated nanoparticles are becoming a compelling biomimetic system for innovative therapeutics. Here, we demonstrate the successful use of cell membrane-coated nanoparticles as building blocks to formulate a colloidal gel that gelates entirely based on material self-assembly without chemical cross-linking. Specifically, we prepare red blood cell membrane-coated nanosponges and mix them with an appropriate amount of cationic nanoparticles, resulting in a spontaneously formed gel-like complex. Rheological test shows that the nanosponge colloidal gel has pronounced shear-thinning property, which makes it an injectable formulation. The gel formulation not only preserves the nanosponges' toxin neutralization capability but also greatly prolongs their retention time after subcutaneous injection into mouse tissue. When tested in a mouse model of subcutaneous group A Streptococcus infection, the nanosponge colloidal gel shows significant antibacterial efficacy by markedly reducing skin lesion development. Overall, the nanosponge colloidal gel system is promising as an injectable formulation for therapeutic applications such as antivirulence treatment for local bacterial infections.

Indexed as

ColloidsErythrocyte MembraneGelsNanoparticlesParticle SizeSurface PropertiesColloidsGelsbacterial infectioncolloidal geldetoxificationnanospongeself-assembly

Identifiers

PMID29116753
PMCPMC6336496
OpenAlexW2767427307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.